American, BA and oneworld launch transatlantic COVID-19 testing trial


The trial aims to scientifically demonstrate how COVID-19 testing can reopen international travel and remove the need for passengers to quarantine on arrival.

American Airlines, British Airways and oneworld have launched an optional COVID-19 medical-based testing trial on selected flights from the United States to London Heathrow (LHR). The trial aims to scientifically demonstrate how COVID-19 testing can reopen international travel and remove the need for passengers to quarantine on arrival.

The free tests will initially be offered to eligible customers booked on select American Airlines flights departing Dallas/Fort Worth to London Heathrow; British Airways departing John F. Kennedy International Airport to LHR; and British Airways from Los Angeles International Airport to LHR, beginning 25 November. The test will later be expanded to a select American Airlines flight from JFK to LHR.

Eligible customers booked on flights that are part of the trial will be contacted by American Airlines and British Airways with instructions on how to volunteer. Each customer participating in the trial will take three tests in conjunction with the journey. If a customer tests positive, they should reschedule or cancel their travel.

The first test, to be taken 72 hours before departure from the US, is a convenient at-home RT-PCR test provided by LetsGetChecked. Customers will self-collect a nasal sample, under the supervision of medical professionals via a virtual visit.

After landing at LHR, participating customers will proceed to their second test at the airport. The so-called LAMP test, provided by Collinson, involves the collection of a nasal sample by a medical professional. After the test is completed, a test kit for the third test will be provided to the customer. The test kit offers an at-home testing option, through the self-collection of a saliva sample which is taken three days after arrival in to the United Kingdom.

The three-test approach aims to validate a customer’s negative status for COVID-19 throughout the travel journey and will provide insight into the most effective and practical testing interval. The third test is intended to further confirm the results of the first two tests, to demonstrate that one or two tests will be sufficient to allow travel to safely restart.

A task force comprising oneworld member airline representatives and independent medical experts are overseeing the implementation of the trial. American Airlines, British Airways and oneworld will closely monitor customer participation. Following the trial, the task force will share aggregated results with the US and UK Governments and other stakeholders to demonstrate the essential role that COVID-19 testing programmes can play in safely restarting travel.

Chairman and Chief Executive of American Airlines, Doug Parker, commented: “American has already successfully introduced a pre-flight COVID-19 testing programme for customers travelling from the US to international destinations across the Caribbean and Latin America. We have received tremendous feedback from our customers in response to testing, as it provides peace of mind for safe and enjoyable travel.

“The UK is a critically important business and leisure destination that our customers want to visit. We believe the results provided by this trial will be vital for reopening transatlantic travel safely.”

Tags


Comments

Leave a comment:

Your email address will not be published.

9 − two =